DYII has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
|Holder||Position||Shares||% of Shares |
|Dr. Ping S. Chu,M.D.||N/A||276,973||2.04%||2007-11-27|
|Dr. Eric K. Chan, M.D.||President and CEO||199,811||1.47%||2012-01-10|
|Mr. Earl R. Votaw||N/A||40,683||0.3%||2008-07-18|
|Mr. James G. Gerace||N/A||25,000||0.18%||2010-04-22|
|Dr. Xiao H. Li,M.D.||N/A||10,333||less than 0.1%||2008-02-15|
|Insider||Position||Date||Buy/Sell||Shares||Shares Owned Following This (Direct & Indirect)||Trade Price ($)||Cost ($1000)||Price Change
Since Trade (%)
|Share Ownership Details|
|Chan Eric K.||President and CEO|
(Click for the stocks that their CEOs have bought)
587,539 (By CEMEKC, Inc.)
|GERACE JAMES G||Director||2010-04-22||Buy||5,000||25,000||$2.8||14||-97.86||Link|
|VOTAW EARL R||Director||2008-07-18||Buy||2,000||40,683||$3.7||7.4||-98.38|
|CHU PING S||Director||2007-11-27||Buy||10,000||276,973||$3.71||37.1||-98.38|
|GERACE JAMES G||Director||2004-11-17||Buy||10,000||10,000||$4.8||48||-98.75||Link|
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.
"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).